A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19

Clinical trial NCT04540185 · UNKNOWN

Trial details

NCT number: NCT04540185
Sponsor: Biomed Industries, Inc.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Covid19 SARS (Severe Acute Respiratory Syndrome)SARS-CoV Infection SARS-CoV-2

Start date: 2020-11-01
Primary completion: 2022-11-01
Enrollment: 3600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.